Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection [Phase 1]
Phase 1 safety study of cord blood–derived cytokine-induced killer (CIK) cells in patients with solid tumors after radical resection. The li…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 trial evaluating thalidomide in combination with doxorubicin chemoembolization for unresectable hepatocellular carcinoma; the study …
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care [Phase 1, Phase 2]
The DENSPM trial in hepatocellular carcinoma patients not eligible for surgical care (Phase 1/2) was terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma [Phase 2]
A Phase 2 safety study of BAY73-4506 in patients with hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant [Phase 1]
A Phase 1 study evaluated sorafenib tosylate in adults with hepatocellular carcinoma or other primary liver cancers after liver transplantat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib [Phase 3]
Phase 3 study evaluating ramucirumab plus best supportive care versus placebo plus best supportive care as second-line treatment for hepatoc…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Testing of ADI-PEG in Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update indicating completion of testing of ADI-PEG 20 in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial of dasatinib for advanced hepatocellular carcinoma that could not be removed surgically was terminated; results were posted in…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: TRC105 for Liver Cancer That Has Not Responded to Sorafenib [Phase 2]
Phase 2 trial of TRC105 for hepatocellular carcinoma that progressed on sorafenib has completed, with results posted on 2015-03-17.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib [Phase 2]
Phase 2b study of the oncolytic vaccinia virus Pexa-Vec (JX-594) in patients with advanced hepatocellular carcinoma after sorafenib failure …
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) [Phase 3]
Phase 3 trial update of telaprevir with standard of care in hepatitis C virus-associated hepatocellular carcinoma has been terminated; resul…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
Completed post-marketing surveillance study of Nexavar (sorafenib) for hepatocellular carcinoma in Japan.
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1-2 trial of CF102 in advanced hepatocellular carcinoma completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC
Clinical trial update on the HDE use protocol of TheraSphere for unresectable hepatocellular carcinoma has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) [Phase 4]
Phase 4 trial evaluating sorafenib dose ramp-up in hepatocellular carcinoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) [Phase 3]
Phase 3 trial investigating talaporfin sodium with interstitial LED therapy for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing Transarterial Ethanol Ablation (TEA) with Transcatheter Arterial Chemoembolisation (TACE) for hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial results update on lapatinib for biliary tract and primary liver cancers that are unresectable or unresected; study co…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer [NA]
This clinical trial update notes an ongoing study investigating whether branched-chain amino acids influence the progression of hepatocellul…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours [Phase 4]
A Phase 4 trial evaluated the effects of dexmedetomidine during radiofrequency ablation of abdominal tumors. The study involving cancers of …
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma
This clinical trial update reports completion of a study evaluating diffusion-weighted imaging MRI (DwI-MR) to predict chemotherapy response…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load [Phase 4]
Phase 4 clinical trial update evaluating prompt monitoring versus watchful waiting for hepatocellular carcinoma related to hepatitis B in pa…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) [Phase 3]
Phase 3 trial update for sorafenib as adjuvant therapy in hepatocellular carcinoma (STORM) completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors [Phase 1]
A Phase 1 study evaluating autologous tumor-infiltrating lymphocytes (TIL) therapy in solid tumors, including nasopharyngeal carcinoma, hepa…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Doxorubicin and Bortezomib in Treating Patients With Liver Cancer [Phase 2]
Phase 2 trial evaluating the combination of doxorubicin and bortezomib for hepatocellular carcinoma has completed, with results posted in 20…